Keywords: Brain, Carnosinase, Neurodegeneration, Oxidative Stress, Alzheimer Disease, Antioxidant Activity, Article, Brain Damage, Brain Hypoxia, Brain Ischemia, Degenerative Disease, Drug Effect, Drug Mechanism, Homeostasis, Human, Huntington Chorea, In Vitro Study, In Vivo Study, Neuroprotection, Nitrosative Stress, Nonhuman, Parkinson Disease, Protein Function, Protein Localization, Animals, Dipeptidases, Neurodegenerative Diseases,
Affiliations: *** IBB - CNR ***
University of Catania, Department of Chemical Sciences, Viale A. Doria 6, 95125 Catania, Italy.
Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, via C. Valeria (Gazzi), 98125, Messina, Italy
IRCCS Centro Neurolesi Bonino-Pulejo, Via Palermo Contrada Casazza, 98100 Messina, Italy
References: Not available.
Neuroprotective features of carnosine in oxidative driven diseases
Carnosine (beta-alanyl-L-histidine) is a natural dipeptide widely and abundantly distributed in excitable tissues of several animal tissues. Although its physiological role has not been completely understood yet, many beneficial actions have been attributed to carnosine, such as being an antioxidant, antiglycating and ion-chelating agent, a wound healing promoter and a free-radical scavenger. The role of carnosine in the neuroprotection of oxidative stress-driven disorders has been reviewed. The effects of carnosine have been extensively studied both in vivo and in vitro models of cerebral damages, such as neurodegenerative disorders and hypoxia-ischemia injuries. Beside the classical sacrificial agent, carnosine has been reevaluated as a molecular chaperon and an inducer of antioxidant systems in oxidative stress conditions. Thus, beneficial effects on most of the common biochemical events that characterize neurological disorders make carnosine a very promising molecule among all the endogenous compounds in the treatment and/or prevention of oxidative driven diseases. Copyright 2011 Elsevier Ltd. All rights reserved.
Neuroprotective features of carnosine in oxidative driven diseases
Ciccarelli M, Sorriento D, Coscioni E, Iaccarino G, Santulli G * Adrenergic Receptors(330 views) Endocrinol Of The Heart In Health And Dis (ISSN: 9780-1280311249780128031117), 2016; N/D: 285-315. Impact Factor:0 ViewExport to BibTeXExport to EndNote
Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, Terni B, Curcio SA, Mirabelli M, Clodomiro A, Di Lorenzo R, Maletta R, Anfossi M, Gallo M, Geracitano S, Tomaino C, Muraca MG, Leotta A, Lio SG, Pinessi L, Rainero I, Sorbi S, Nee L, Milan G, Pappata S, Postiglione A, Abbamondi N, Forloni G, St George Hyslop P, Rogaeva E, Bugiani O, Giaccone G, Foncin JF, Spillantini MG, Puccio G * Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation(1433 views) Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2010 Mar 9; 74(10): 798-806. Impact Factor:8.017 ViewExport to BibTeXExport to EndNote